Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.86 USD | +4.65% | +11.33% | -22.52% |
28/06 | Cytosorbents Corporation announced that it expects to receive $20 million in funding | CI |
24/06 | CytoSorbents' Blood Purification Device Gets Approval in Taiwan | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
9,298 PTS | 0.00% | +3.99% | - | ||
359.1 PTS | +0.51% | +2.50% | - | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.52% | 4.67Cr | |
+0.91% | 20TCr | |
+3.74% | 18TCr | |
+28.89% | 15TCr | |
+31.66% | 11TCr | |
+1.37% | 6.42TCr | |
+19.45% | 5.49TCr | |
-2.27% | 4.67TCr | |
-9.28% | 3.68TCr | |
-0.10% | 3.53TCr |
- Stock Market
- Equities
- CTSO Stock
- News Cytosorbents Corporation
- CytoSorbents Announces Commercial Launch and Immediate Availability of CytoSorb To Treat Cytokine Storm In Many Latin American Countries As COVID-19 Cases Rise